ARCHIVES

ODAC Recommends Approval of Evista for Breast Cancer Risk Reduction.

This article is from The Cancer Letter archive.

Vol. 33 No. 29 | July 27, 2007

Download PDF Visit The Full Archive

Related Articles

NEW OIG Awards Bring Total to 58

November 13, 1987

House Launches Probe of NCI Spending On Cancer Communications, Education

April 12, 2013

New Agency To Evaluate PDQ; NCAB Approves NCI Payment Of Part

June 1, 1990

NCAB Ponders Patient Accrual Problems, Members Irate Over System That Discourages Participation

February 19, 1988

Guest Editorial: As Sequestration Becomes More Likely, Health Groups Must Make Themselves Heard

February 22, 2013

Breast Cancer Strategic Plan Underway Following HHS Secretary’s Conference

January 7, 1994